| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.8M | — | +26.0% |
| Cost of Revenue | $2.4M | — | -19.9% |
| Gross Profit | $15.3M | — | +38.5% |
| R&D Expense | $9.2M | — | +90.8% |
| SG&A Expense | $7.0M | — | -13.6% |
| Operating Income | -$5.7M | — | +71.2% |
| Pre-tax Income | -$5.7M | — | +70.0% |
| Income Tax | $136K | — | -36.2% |
| Net Income | -$5.9M | — | +69.6% |
| EPS (Basic) | -$0.19 | — | +71.6% |
| EPS (Diluted) | -$0.19 | — | +71.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.9M | +21.3% | -63.0% |
| Accounts Receivable | $9.2M | -5.3% | +58.9% |
| Current Assets | $38.2M | -17.2% | -61.8% |
| Total Assets | $111.5M | -9.1% | -19.3% |
| Current Liabilities | $27.0M | -29.8% | -42.3% |
| Total Liabilities | $34.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.0M | — | -871.1% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $1.0M | — | -91.2% |
| Financing Cash Flow | $3.7M | — | +833.2% |
| Free Cash Flow | -$11.0M | — | -795.4% |
| -36.3% |
| Stockholders' Equity | $76.7M | +2.3% | -8.2% |